Search for a command to run...

Timestamps are as accurate as they can be but may be slightly off. We encourage you to listen to the full context.
In this Tokyo episode of This Week in Startups, host Jason Calacanis sits down with two fascinating guests to discuss the future of AI in healthcare and Japan's evolving venture capital landscape. (00:55) Fred Almeida, founder and CEO of American Medical Intelligence Inc., shares his bold vision that AI will soon become people's primary care doctor, fundamentally disrupting how diagnostic clinics operate. (05:29) Meanwhile, Maxwell Weiss from Pacific Bays Capital explains why Japan has entered "decade two" of its venture capital journey, focusing on aerospace, defense, and energy investments that leverage Japan's hidden strengths in materials and semiconductors. (13:33) The episode concludes with live pitches from five Japanese startups from Founder University, showcasing everything from AI-powered ad optimization to anonymous social networking platforms designed to combat Japan's loneliness epidemic.
• Main Theme: The intersection of AI innovation, healthcare disruption, and Japan's emerging startup ecosystem, featuring live startup pitches and investment insights from Tokyo
Jason Calacanis is the host of This Week in Startups and founder of Founder University, a pre-accelerator program for early-stage startups. He's an accomplished angel investor with notable investments in companies like Robinhood, Uber, and Calm, and has been instrumental in launching startup ecosystems globally, including recent expansions to Tokyo, Saudi Arabia, and the United States.
Fred Almeida is the founder and CEO of American Medical Intelligence Inc., an AI-focused healthcare platform that combines clinic roll-ups with artificial intelligence to revolutionize diagnostic care. He has previously built robotics and self-driving car companies in Tokyo since 2016, establishing himself as a pioneer in AI and autonomous systems development in Japan.
Maxwell Weiss is a partner at Pacific Bays Capital, a venture capital firm focused on aerospace, defense, space, energy, and economic security investments. He specializes in identifying opportunities that leverage Japan's technical strengths in materials and semiconductors while fostering stronger US-Japan partnerships in critical technology sectors.
Fred Almeida predicts that AI will become people's primary care physician in the near future, with patients going directly to diagnostic tools rather than traditional doctor visits. (05:29) This radical shift addresses the shortage of general practitioners and the inefficiency of current healthcare delivery. The AI would analyze symptoms, recommend appropriate tests, and only refer patients to human specialists when necessary. This approach could catch diseases earlier, reduce costs, and eliminate the bureaucratic friction that currently drives talented doctors away from medicine. For professionals, this represents both a threat to traditional healthcare roles and an opportunity to embrace technology-enabled healthcare delivery.
Maxwell Weiss explains that Japan is transitioning from a consumer and SaaS-focused first decade to a more sophisticated venture ecosystem leveraging the country's technical manufacturing expertise. (13:33) Unlike the previous generation that sought lifetime employment at large corporations, young Japanese professionals now increasingly prefer entrepreneurship. This shift creates unprecedented opportunities for startups that can bridge Japan's technical capabilities in materials and semiconductors with global market opportunities. Professionals should recognize Japan as an emerging startup hub rather than just a mature corporate economy.
Rather than waiting for symptoms to worsen through multiple doctor visits, the future lies in proactive diagnostic testing guided by AI analysis. (09:02) Fred describes how getting comprehensive blood work twice yearly, combined with AI analysis, can identify health issues before they become serious problems. This approach is not only more effective for early disease detection but also more cost-effective than traditional reactive healthcare. Professionals should consider adopting proactive health monitoring strategies, using services like Function Health or similar platforms to stay ahead of potential health issues.
Maxwell identifies a cultural phenomenon called "English allergy" where technically capable Japanese professionals avoid English-speaking markets due to fear of embarrassment rather than language inability. (25:41) This risk aversion, rooted in "genten shugi" (being judged by mistakes rather than accomplishments), creates opportunities for cross-cultural teams. American entrepreneurs can partner with Japanese technical talent to create hybrid teams that combine American market aggressiveness with Japanese technical discipline and precision.
The current healthcare system incentivizes doctors to maximize office visits rather than efficient diagnosis and treatment. (10:37) Insurance pre-authorization requirements and bureaucratic overhead force doctors to spend time on paperwork instead of patient care, leading to talented physicians wanting to quit medicine. A reformed system would flip this model: AI handles initial diagnosis, comprehensive testing happens upfront, and doctors focus on higher-level medical decision-making and complex cases. This creates better outcomes for patients while making medicine more rewarding for practitioners.